$ARBE Cashflow Statement | Understand Stock

$ARBE

$0.42 -$0.01 (2.76%) Close

$ARBE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net loss
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Stock-based compensation
Stock-based compensation to service providers
Revaluation of warrants
Revaluation of convertible bonds
Issuance costs related to convertible bonds
Finance income, net
Change in operating assets and liabilities:
Trade receivable, net
Prepaid expenses and other receivables
Operating lease ROU assets and liabilities, net
Trade payables
Employees and payroll accruals
Derivative Liabilities
Deferred revenue
Accrued expenses and other payables
Net cash used in operating activities
Cash flows from investing activities:
Change in bank deposits
Purchase of property and equipment
Net cash provided by (used in) investing activities
Proceeds from short-term loan
Repayment of long-term loan
Proceeds from recapitalization and PIPE offering, net of issuance costs

Repayment of short-term loan
Cash flows from financing activities:
Exercise of warrants into convertible preferred shares
Issuance of private warrants
Conversion of convertible loan into ordinary shares upon the recapitalization
Conversion of preferred shares into ordinary shares upon the recapitalization
Purchase of property and equipment
Issuance of convertible bonds with proceeds placed in escrow
Lease liabilities arising from obtaining right-of-use assets
Issuance costs related to convertible bonds
Proceeds from conversion of convertible debentures
Proceeds from exercise of warrants
Proceeds from exercise of options
Net cash provided by financing activities
Effect of exchange rate fluctuations on cash and cash equivalent
Decrease in cash, cash equivalents and restricted cash
Effect of exchange rate fluctuations on cash and cash equivalent included in Finance income

Cash, cash equivalents and restricted cash at the beginning of the year
Cash, cash equivalents and restricted cash at the end of the year
Exercise of warrants into convertible preferred shares
Issuance of private warrants
Supplemental non-cash disclosure:
Issuance of convertible bonds with proceeds placed in escrow
Exercise of warrants
Lease liabilities arising from obtaining right-of-use assets
Purchase of property and equipment
Supplemental disclosure of cash flows activities:
Interest paid

Comments